NCT02331407

Brief Summary

Stroke is a leading cause of neurological disability worldwide, often causing significant weakening and paresis of the affected arm. National spending on post-stroke rehabilitation is project to expand 20% to 35% through 2010. As a new tool for therapists, robotic stroke therapy devices have the potential to be a cost-effective device aid to physical therapy and enable novel modes of exercise not currently available. While recent studies have shown chronic patients benefit from repetitive practice, it is not clear whether they improved via a reduction in impairment or increased functional compensation because there is a lack of standard treatment and scales to assess rehabilitation efficacy in chronic stroke patients. This study aims to reconcile difference performance measurements in robotic rehabilitation to assess the outcome of robotic rehabilitation training.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started Oct 2008

Typical duration for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2008

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2011

Completed
3.7 years until next milestone

First Submitted

Initial submission to the registry

January 1, 2015

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 6, 2015

Completed
4.3 years until next milestone

Results Posted

Study results publicly available

May 7, 2019

Completed
Last Updated

May 7, 2019

Status Verified

April 1, 2019

Enrollment Period

2.6 years

First QC Date

January 1, 2015

Results QC Date

March 27, 2019

Last Update Submit

April 18, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Arm Motor Control From Baseline Measured as Average Squared Mahalanobis Distance

    Arm motor control was assessed through analysis of reaching movements to targets. We derive a measure of arm motor control using functional principal components analysis of reaching trajectories (average squared Mahalanobis distance). This is a unitless measure and lower change values reflect improvement in motor control, while a higher change value reflect a worsening in motor control.

    From baseline to within 1 week post-therapy

Secondary Outcomes (2)

  • Fugl-Meyer (FM) Upper Extremity Motor Assessment

    baseline (1 and 3 weeks prior to therapy), within 1 week after therapy, 3 weeks after therapy

  • Action Research Arm Test

    baseline (1 and 3 weeks prior to therapy), within 1 week after therapy, 3 weeks after therapy

Study Arms (1)

Robot arm rehabilitation therapy

EXPERIMENTAL

Arm training using the ReoGo robotic device, 3 times a week for 3 weeks.

Device: Robotic arm therapy

Interventions

Training with the ReoGo device

Robot arm rehabilitation therapy

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hemiparesis of the upper extremity
  • Diagnosis of a first clinically apparent ischemic stroke at least 6 months prior to study entry
  • Age 18 years or older
  • Ability to sit and be active for an hour on a chair (or wheelchair) without cardiac, respiratory disturbances and/or pain.

You may not qualify if:

  • Inability to understand and/or follow instructions
  • Pain in shoulder or arm
  • Other neurological or musculoskeletal target organ disorder
  • Inability to give informed consent personally
  • Previous or current contracture of the upper extremity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Columbia Univeristy, Neurological Institute

New York, New York, 10032, United States

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Results Point of Contact

Title
Dr. Tomoko Kitago
Organization
Columbia University

Study Officials

  • John Krakauer, MD

    Columbia University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 1, 2015

First Posted

January 6, 2015

Study Start

October 1, 2008

Primary Completion

May 1, 2011

Study Completion

May 1, 2011

Last Updated

May 7, 2019

Results First Posted

May 7, 2019

Record last verified: 2019-04

Locations